{"contentid": 488393, "importid": NaN, "name": "Russian pharma production booming, anticipating third wave of pandemic", "introduction": "Russian pharmaceutical production is booming, according to latest statistics provided by some leading analyst agencies in the field of pharmaceutics and local media reports.", "content": "<p>Russian pharmaceutical production is booming, according to latest statistics provided by some leading analyst agencies in the field of pharmaceutics and local media reports.&nbsp;</p>\n<p>According to data of RNC Pharma agency, in January-February 2021 of the current year, production grew by 61% in value terms compared to the same period last year and reached 101.4 billion roubles ($1.32 billion).&nbsp;</p>\n<p>Nikolay Bespalov, development director of RNC Pharma, said in an interview with Russian Lenta business paper, such a growth was mainly due to the effect of low base, as manufacturers are now ramping up production in anticipation of the third wave of coronavirus.&nbsp;</p>\n<p>In addition, according to him, another reason for growth is the rise in prices for imported drugs into the Russian market. Since domestic drugs are 2.5-3 times cheaper than their foreign equivalents, the consumer makes a choice in favor of Russian products, thereby also stimulating demand.</p>\n<p>In the first two months of 2021, 231 corporations were engaged in shipments of prescription drugs in Russia with Binnopharm Group, which was established in 2020 as a result of the merger of pharmaceutical assets of AFK Sistema) being a leader.&nbsp;&nbsp;</p>\n<p>Last year, the holding took first place in Russia in the production of antibiotics. Binnopharm Group currently remains the largest manufacturer of antibiotics in Russia and the company has the largest portfolio of antibiotics.&nbsp;</p>\n<p>The group owns the Sintez plant in Kurgan, which has historically focused on the development of the production of antibacterial drugs.</p>\n<p>&nbsp;</p>", "date": "2021-04-20 10:51:00", "meta_title": "Russian pharma production booming, anticipating third wave of pandemic", "meta_keywords": "Russia, Production, Binnopharm Group", "meta_description": "Russian pharma production booming, anticipating third wave of pandemic", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-19 17:10:21", "updated": "2021-04-20 10:51:55", "access": NaN, "url": "https://www.thepharmaletter.com/article/russian-pharma-production-booming-anticipating-third-wave-of-pandemic", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "russia_roubles_rubles_money_big.jpg", "image2id": "russia_roubles_rubles_money_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Generics", "therapy area_tag": "Antibiotics", "topic_tag": "Focus On, Production, Russian market", "geography_tag": "Russia", "company_tag": "Binnopharm", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-20 10:51:00"}